Description
Primcyv™ is a licensed generic of Ibrance® produced by Dr. Reddy’s Laboratories®, a US FDA certified manufacturer, in India. It’s used to treat adults with HR+ and HER2- advanced or metastatic breast cancer (mBC) in combination with an aromatase inhibitor as initial hormonal based therapy, or fulvestrant in patients with disease progression after hormonal therapy.
Package Size : 21 Capsules
Active Ingredient : Palbociclib
Produced by Dr. Reddy’s Laboratories®